Skip to main navigation Skip to search Skip to main content

AST is a novel anti-carcinogenic regimen against gastrointestinal cancer development with unique molecular targets (Abstract)

  • Joshua Ko*
  • , Kathy K W Auyeung
  • *Corresponding author for this work

Research output: Contribution to journalConference articlepeer-review

Fingerprint

Dive into the research topics of 'AST is a novel anti-carcinogenic regimen against gastrointestinal cancer development with unique molecular targets (Abstract)'. Together they form a unique fingerprint.
Sort by:

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science